BCL10.md
... ...
@@ -27,7 +27,6 @@ timeline
27 27
|![MZL](images/icons/MZL_tier1.png)|1|high-confidence MZL gene[@spinaGeneticsNodalMarginal2016b]|
28 28
|![DLBCL](images/icons/DLBCL_tier1.png) |1 |high-confidence DLBCL gene[@morinFrequentMutationHistonemodifying2011] |
29 29
|![FL](images/icons/FL_tier2.png) |2 |relevance in FL not firmly established[@russler-germainMutationsAssociatedProgression2023b]|
30
-|![BL](images/icons/BL_tier2.png) |2 |relevance in BL not firmly established|
31 30
32 31
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
33 32
BIRC6.md
... ...
@@ -25,7 +25,6 @@ timeline
25 25
|![PMBL](images/icons/PMBL_tier1.png)|1|high-confidence PMBL/cHL/GZL gene [@sarkozyMutationalLandscapeGray2021a]|
26 26
|![DLBCL](images/icons/DLBCL_tier1.png) |1 |high-confidence DLBCL gene [@reddyGeneticFunctionalDrivers2017]|
27 27
|![FL](images/icons/FL_tier1.png) |1 |high-confidence FL gene |
28
-|![BL](images/icons/BL_tier2.png) |2 |relevance in BL not firmly established|
29 28
30 29
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
31 30
CARD11.md
... ...
@@ -26,7 +26,6 @@ timeline
26 26
|![FL](images/icons/FL_tier1.png) |1 |high-confidence FL gene [@morinFrequentMutationHistonemodifying2011]|
27 27
|![MCL](images/icons/MCL_tier1.png) |1 |high-confidence MCL gene [@wuGeneticHeterogeneityPrimary2016]|
28 28
29
-|![BL](images/icons/BL_tier2.png)|2|relevance in BL not firmly established|
30 29
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
31 30
32 31
|Entity|source |frequency (%)|
CD79B.md
... ...
@@ -30,7 +30,7 @@ timeline
30 30
|:------:|:----:|--------------------------------------|
31 31
|![DLBCL](images/icons/DLBCL_tier1.png) |1 |high-confidence DLBCL gene [@morinFrequentMutationHistonemodifying2011]|
32 32
|![FL](images/icons/FL_tier2.png) |2 |relevance in FL not firmly established|
33
-|![BL](images/icons/BL_tier2.png) |2-F |Failed QC|
33
+|![BL](images/icons/BL_tier2.png) |2-F |Failed QC[@paneaWholeGenomeLandscape2019]|
34 34
35 35
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
36 36
EP300.md
... ...
@@ -26,7 +26,6 @@ timeline
26 26
|![DLBCL](images/icons/DLBCL_tier1.png) |1 |high-confidence DLBCL gene [@pasqualucciInactivatingMutationsAcetyltransferase2011a]|
27 27
|![FL](images/icons/FL_tier1.png) |1 |high-confidence FL gene [@pasqualucciInactivatingMutationsAcetyltransferase2011a]|
28 28
29
-|![BL](images/icons/BL_tier2.png)|2|relevance in BL not firmly established|
30 29
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
31 30
32 31
|Entity|source |frequency (%)|
GRB2.md
... ...
@@ -25,7 +25,6 @@ timeline
25 25
|:------:|:----:|--------------------------------------|
26 26
|![DLBCL](images/icons/DLBCL_tier1.png) |1 |high-confidence DLBCL gene [@pasqualucciAnalysisCodingGenome2011]|
27 27
28
-|![BL](images/icons/BL_tier2.png)|2|relevance in BL not firmly established|
29 28
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
30 29
31 30
|Entity|source |frequency (%)|
HIST1H1B.md
... ...
@@ -23,7 +23,6 @@ timeline
23 23
|Entity|Tier|Description |
24 24
|:------:|:----:|--------------------------------------|
25 25
|![PMBL](images/icons/PMBL_tier1.png)|1|high-confidence PMBL/cHL/GZL gene[@sarkozyMutationalLandscapeGray2021a]|
26
-|![BL](images/icons/BL_tier2.png) |2 |relevance in BL not firmly established|
27 26
|![DLBCL](images/icons/DLBCL_tier1.png) |1 |high-confidence DLBCL gene [@chapuyMolecularSubtypesDiffuse2018b]|
28 27
|![FL](images/icons/FL_tier1.png) |1 |high-confidence FL gene [@krysiakRecurrentSomaticMutations2017b]|
29 28
HIST1H1C.md
... ...
@@ -30,7 +30,7 @@ timeline
30 30
|![PMBL](images/icons/PMBL_tier1.png)|1|high-confidence PMBL/cHL/GZL gene|
31 31
|![DLBCL](images/icons/DLBCL_tier1.png) |1 |high-confidence DLBCL gene [@morinFrequentMutationHistonemodifying2011]|
32 32
|![FL](images/icons/FL_tier1.png) |1 |high-confidence FL gene [@morinFrequentMutationHistonemodifying2011]|
33
-|![BL](images/icons/BL_tier2.png) |2-F |Failed QC|
33
+|![BL](images/icons/BL_tier2.png) |2-F |Failed QC[@paneaWholeGenomeLandscape2019]]|
34 34
35 35
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
36 36
HIST1H1D.md
... ...
@@ -24,7 +24,6 @@ timeline
24 24
|:------:|:----:|--------------------------------------|
25 25
|![PMBL](images/icons/PMBL_tier1.png)|1|high-confidence PMBL/cHL/GZL gene|
26 26
|![MZL](images/icons/MZL_tier2.png)|2|relevance in MZL not firmly established[@jalladesExomeSequencingIdentifies2017]|
27
-|![BL](images/icons/BL_tier2.png) |2 |relevance in BL not firmly established|
28 27
|![DLBCL](images/icons/DLBCL_tier1.png) |1 |high-confidence DLBCL gene [@morinMutationalStructuralAnalysis2013]|
29 28
|![FL](images/icons/FL_tier1.png) |1 |high-confidence FL gene [@krysiakRecurrentSomaticMutations2017b]|
30 29
HLA-A.md
... ...
@@ -22,7 +22,6 @@ timeline
22 22
|Entity|Tier|Description |
23 23
|:------:|:----:|--------------------------------------|
24 24
|![PMBL](images/icons/PMBL_tier2.png)|2|relevance in PMBL/cHL/GZL not firmly established[@deschGenotypingCirculatingTumor2020]|
25
-|![BL](images/icons/BL_tier2.png) |2 |relevance in BL not firmly established|
26 25
|![DLBCL](images/icons/DLBCL_tier1.png) |1 |high-confidence DLBCL gene [@lohrDiscoveryPrioritizationSomatic2012a]|
27 26
28 27
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
HLA-B.md
... ...
@@ -22,7 +22,6 @@ timeline
22 22
|Entity|Tier|Description |
23 23
|:------:|:----:|--------------------------------------|
24 24
|![PMBL](images/icons/PMBL_tier1.png)|1|high-confidence PMBL/cHL/GZL gene[@wienandGenomicAnalysesFlowsorted2019b]|
25
-|![BL](images/icons/BL_tier2.png) |2 |relevance in BL not firmly established|
26 25
|![DLBCL](images/icons/DLBCL_tier1.png) |1 |high-confidence DLBCL gene [@lohrDiscoveryPrioritizationSomatic2012a]|
27 26
|![FL](images/icons/FL_tier2.png) |2 |relevance in FL not firmly established|
28 27
HLA-DMB.md
... ...
@@ -12,7 +12,6 @@ HLA-DMB, along with HLA-DMA, plays a critical role in the proper functioning of
12 12
13 13
|Entity|Tier|Description |
14 14
|:------:|:----:|--------------------------------------|
15
-|![BL](images/icons/BL_tier2.png) |2 |relevance in BL not firmly established|
16 15
|![DLBCL](images/icons/DLBCL_tier1.png) |1 |high-confidence DLBCL gene |
17 16
18 17
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
KLHL6.md
... ...
@@ -26,7 +26,6 @@ timeline
26 26
|![DLBCL](images/icons/DLBCL_tier1.png) |1-a | aSHM target and high-confidence DLBCL gene [@morinFrequentMutationHistonemodifying2011]|
27 27
|![FL](images/icons/FL_tier1.png) |1-a | aSHM target and high-confidence FL gene [@morinFrequentMutationHistonemodifying2011]|
28 28
29
-|![BL](images/icons/BL_tier2.png)|2|relevance in BL not firmly established|
30 29
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
31 30
32 31
|Entity|source |frequency (%)|
LCOR.md
... ...
@@ -21,8 +21,6 @@ timeline
21 21
|Entity|Tier|Description |
22 22
|:------:|:----:|--------------------------------------|
23 23
|![DLBCL](images/icons/DLBCL_tier1.png) |1 |high-confidence DLBCL gene [@arthurGenomewideDiscoverySomatic2018]|
24
-|![BL](images/icons/BL_tier2.png) |2 |relevance in BL not firmly established|
25
-
26 24
27 25
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
28 26